ArticleMolecular cancer therapeutics2021

Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma.

Shogo Shigeta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.